Sagility: Business Overview & Financial Analysis
Sagility India is a technology-enabled healthcare business process management (BPM) services provider headquartered in Bengaluru, Karnataka. Formerly known as Hinduja Global Solutions Healthcare, the company provides specialized domain-focused solutions to healthcare payers (commercial and government-sponsored health insurance companies) and healthcare providers (hospitals, physician groups, and allied networks) in the United States. Sagility India manages core administrative, operational, and clinical workflows including claims management, payment integrity, clinical services, member engagement, and revenue cycle management (RCM).
Revenue Breakdown by Business Segment of Sagility India (FY26)
Sagility India categorizes its operating turnover across Payers and Providers segments within the US healthcare ecosystem.
- Payers Segment (Health Insurance Plans) – 88.5% of Total Operating Revenue
- Providers Segment (Hospitals & Physician Groups) – 11.5% of Total Operating Revenue
- Total Consolidated Revenue from Operations (FY26) – Rs 5,240.80 crore (+14.5% YoY)
The Payers segment forms the primary revenue foundation, providing end-to-end claims adjudication, member enrollment, and clinical management for US health insurers. The Providers division offers revenue cycle management and clinical documentation services to hospital chains and physician networks across North America.
Client Concentration & Relationship Tenure Metrics of Sagility India (FY26)
Sagility India tracks client concentration and customer retention rates across top healthcare payer accounts in the US market.
- Top 5 Client Accounts Share – 64.2% of Total Operating Revenue
- Top 10 Client Accounts Share – 78.5% of Total Operating Revenue
- Average Client Relationship Tenure (Top 10 Clients) – 12.5 years
- Net Revenue Retention Rate (NRR) – 108.5%
- Total Active Enterprise Clients Base – 65+ Healthcare Organisations
Client relationships demonstrate high stickiness with an average tenure of 12.5 years among top accounts. Deep technical integration across payer claims platforms supports high customer retention and cross-selling opportunities.
Delivery Center Footprint & Global Workforce Scale of Sagility India (Q4 FY26)
Sagility India operates a global delivery footprint spanning onshore US centers, nearshore locations, and offshore delivery hubs in India and the Philippines.
- Total Operational Delivery Centers – 31 facilities across 5 countries
- Total Global Employee Headcount – 38,500+ professionals
- Offshore Delivery Share (India & Philippines) – 82.0% of Total Workforce
- Onshore & Nearshore Delivery Share (US, Jamaica, Colombia) – 18.0% of Total Workforce
- Primary Delivery Hubs – Bengaluru, Hyderabad, Chennai (India), Manila, Iloilo (Philippines), and Denver (US)
Offshore delivery centers in India and the Philippines execute over four-fifths of total client service workflows, driving operational delivery efficiencies. Onshore US locations handle specialized clinical reviews, high-touch member interactions, and key account management.
Service Line Revenue Breakdown & Solutions Portfolio of Sagility India (FY26)
Sagility India structures its healthcare BPM service offerings across claims management, clinical services, payment integrity, and member engagement.
- Claims Administration & Operations – 42.0% of Total Revenue
- Clinical & Medical Management Services – 28.0% of Total Revenue
- Provider Network & Revenue Cycle Services – 18.0% of Total Revenue
- Payment Integrity & Analytics – 12.0% of Total Revenue
Claims administration and clinical management represent seven-tenths of total turnover, benefiting from complex US healthcare regulations and annual member enrollment cycles. Clinical services utilize licensed nurses and healthcare professionals for utilization management and care coordination.
Technology & AI Integration Metrics of Sagility India (FY26)
Sagility India deploys proprietary AI tools, robotic process automation (RPA), and analytics platforms to automate healthcare workflows.
- Automated Claims Processing Share – >65% of routine claims processed using automated workflows
- Proprietary Technology Accelerators – Sagility CareX, Sagility ClaimsX, and Sagility Analytics Engine
- Registered Nurses & Clinical Specialists Staff – 2,800+ certified clinical professionals
- Annual Automation Hours Saved – 4.5+ million operational hours automated annually
Proprietary technology platforms process over 65% of routine payer claims through straight-through processing. A dedicated team of 2,800+ registered nurses and medical specialists performs complex clinical reviews and prior-authorization decisions.
Latest Quarterly Financial Performance of Sagility India (Q4 FY26)
Sagility India recorded top-line revenue expansion and operating EBITDA growth during the fourth quarter of FY26.
- Consolidated Revenue from Operations – Rs 1,385.40 crore (+15.2% YoY)
- US Dollar Revenue – $165.2 million (+12.8% YoY in Constant Currency)
- Consolidated Operating EBITDA – Rs 325.20 crore (+18.5% YoY)
- Consolidated Operating EBITDA Margin – 23.47% (+65 bps YoY)
- Consolidated Net Profit After Tax (PAT) – Rs 198.50 crore (+21.4% YoY)
Fourth-quarter operating revenue rose 15.2% year-on-year to Rs 1,385.40 crore, supported by volume growth in payer claims administration and new client additions. Consolidated Net Profit After Tax expanded 21.4% to Rs 198.50 crore, with operating EBITDA margins widening to 23.47%.
Consolidated Annual Financial Performance of Sagility India (FY26)
Sagility India delivered record operating turnover and net profit growth for full financial year FY26.
- Full Year Consolidated Revenue from Operations – Rs 5,240.80 crore (+14.5% YoY)
- US Dollar Revenue – $628.5 million (+12.5% YoY in Constant Currency)
- Full Year Consolidated Operating EBITDA – Rs 1,215.80 crore (+17.2% YoY)
- Full Year Operating EBITDA Margin – 23.20% (+54 bps YoY)
- Consolidated Net Profit After Tax (PAT) – Rs 725.40 crore (+22.8% YoY)
- Return on Capital Employed (ROCE) – 18.5%
Full-year operating turnover crossed Rs 5,240 crore in FY26, as consolidated Net Profit After Tax expanded 22.8% to Rs 725.40 crore. Operational performance was driven by offshore execution leverage, expansion in clinical services, and client contract renewals.
Balance Sheet Structure & Financial Health Ratios of Sagility India (Q4 FY26)
Sagility India maintains a healthy capital structure supported by strong operational cash flow generation and deleveraging.
- Net Debt to Operating EBITDA Ratio – 0.82x (reduced from 1.25x in FY25)
- Cash, Bank Balances & Liquid Surplus – Rs 850 crore
- Return on Equity (ROE) – 16.8%
- Working Capital Cycle – 58 days
- Free Cash Flow (FCF) Conversion Rate – 68.0% of Operating EBITDA
Net debt compressed significantly during Q4 FY26, bringing the Net Debt to EBITDA ratio down to 0.82x. Free cash flow generation remained strong, converting 68% of operating EBITDA into free cash accruals.
Capacity Expansion & Delivery Center Outlay of Sagility India (FY27–FY28)
Sagility India executes capital allocation plans to expand delivery seat capacity across offshore and nearshore centers.
- Total Planned Delivery Seats Addition – 3,500+ additional seats over FY27–FY28
- Planned Annual Capital Expenditure – Rs 180–220 crore per annum
- Geographic Facility Expansion – Expanding seat capacity in Hyderabad (India), Iloilo (Philippines), and Kingston (Jamaica)
- Technology Capex Allocation – Investing in generative AI tools and HIPAA-compliant cloud infrastructure
- Funding Strategy – 100% funded through internal operational cash generation
Annual capital expenditure is budgeted at Rs 180–220 crore to construct new delivery facilities and deploy generative AI tools. Operational cash flows fund all planned seat expansions and technology upgrades without debt reliance.
Management Commentary & Strategic Outlook of Sagility India (Q4 FY26 / FY27)
Management guidance outlines strategic priorities centered on US healthcare market penetration, provider segment growth, and margin expansion.
- Management targets achieving a 12%–15% US Dollar revenue CAGR in Constant Currency terms over the FY27–FY29 period.
- Consolidated Operating EBITDA margins are guided to sustain within the 23.0%–24.5% corridor through offshore delivery leverage.
- Provider segment revenue contribution is targeted to expand toward 15% of total turnover over the next 3 years.
- Artificial Intelligence and automation initiatives will focus on automating clinical prior-authorizations and payment integrity workflows.
- Strategic M&A opportunities will be evaluated in specialized analytics and payment integrity niches using surplus cash reserves.
Management anticipates US healthcare outsourcing demand to remain robust, driven by administrative cost pressures on insurers and complex regulatory compliance requirements. Operational focus centers on scaling offshore delivery seats, expanding AI-led automation solutions, and driving market share gains across payer and provider segments.
Want to filter out stocks using your own financial benchmarks? You can use the Stock Screener on Finology Ticker to identify and compare companies based on specific growth and efficiency metrics.
Sources & References
- Sagility India Q4 & Full Year FY26 Consolidated Financial Disclosures (May 2026)
- Sagility India Q4 FY26 Investor Presentation & Press Release (May 2026)
- BSE India & NSE Official Corporate Announcements for Sagility India
- Ticker Finology Sagility Page
Disclaimer
The information presented above on Sagility India has been compiled from the company's Annual Reports, Investor Presentations, Earnings Call (Concall) Transcripts, official regulatory filings and the financial data available on Finology Ticker. Certain figures, classifications or comparisons may vary due to differences in accounting policies, reporting methodologies or subsequent restatements by the company. This content is intended solely for informational purposes and should not be considered as investment advice. Investors are advised to refer to the latest company filings and the updated financial data, ratios and disclosures available on this Finology Ticker Sagility India page before making any investment decision. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.